From M-tuberculosis thymidine monophosphate kinase (TMPKmt) inhibitors towards mitochondrial thymidine kinase (TK-2) inhibitors

被引：0

作者：

Van Calenbergh, Serge ^{[1
]}

Van Daele, Ineke ^{[1
]}

Van Poecke, Sara ^{[1
]}

Froeyen, Matheus

Lehmann, Helene Munier

Balzarini, Jan

机构：

[1] Univ Ghent, Lab Med Chem FFW, B-9000 Ghent, Belgium

来源：

CHEMISTRY OF NUCLEIC ACID COMPONENTS | 2008年 / 10卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Here, we report on the enzyme structure-aided design of a series of substituted 3'- or 5'-thiourea derivatives of beta- and alpha-thymidine, respectively, as thymidine monophosphate kinase inhibitors of M. tuberculosis. In a recent study, several 3'-thiourea substituted thymidine derivatives were found to be exquisitely potent and specific inhibitors of mitochondrial thymidine kinase (TK-2), with high selectivity when compared with cytosolic TK-1.

引用

页码：87 / 93

页数：7

共 50 条

[41] PURIFICATION AND PROPERTIES OF THYMIDINE MONOPHOSPHATE KINASE FROM MOUSE HEPATOMA
KIELLEY, RK
JOURNAL OF BIOLOGICAL CHEMISTRY, 1970, 245 (16) : 4204 - &
[42] Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
Garone, Caterina
Garcia-Diaz, Beatriz
Emmanuele, Valentina
Lopez, Luis C.
Tadesse, Saba
Akman, Hasan O.
Tanji, Kurenai
Quinzii, Catarina M.
Hirano, Michio
EMBO MOLECULAR MEDICINE, 2014, 6 (08) : 1016 - 1027
[43] Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase ( TMPKmt) inhibition activity and molecular modelling studies
El-Shoukrofy, Mai S.
Atta, Amal
Fahmy, Salwa
Sriram, Dharmarajan
Shehat, Michael G.
Labouta, Ibrahim M.
Mahran, Mona A.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01)
[44] 2′-O-acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase
Balzarini, J
Degrève, B
Zhu, CY
Durini, E
Porcu, L
De Clercq, E
Karlsson, A
Manfredini, S
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (06) : 727 - 732
[45] Cloning of mouse mitochondrial thymidine kinase 2 cDNA
Wettin, K
Johansson, M
Zheng, XY
Zhu, CY
Karlsson, A
FEBS LETTERS, 1999, 460 (01) : 103 - 106
[46] 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods
Aparna, V
Jeevan, J
Ravi, M
Desiraju, GR
Gopalakrishnan, B
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) : 1014 - 1020
[47] mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency
Saada, A
Shaag, A
Elpeleg, O
MOLECULAR GENETICS AND METABOLISM, 2003, 79 (01) : 1 - 5
[48] Quantitative structure-activity relationships and design of thymine-like inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis with favourable pharmacokinetic profiles
Keita, M.
Kumar, A.
Dali, B.
Megnassan, E.
Siddiqi, M. I.
Frecer, V.
Miertus, S.
RSC ADVANCES, 2014, 4 (99) : 55853 - 55866
[49] Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase
Lock, MJ
Thorley, N
Teo, J
Emery, VC
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) : 359 - 366
[50] FURTHER INSIGHTS IN THE INHIBITORY ACTIVITY OF ACYCLIC THYMINE NUCLEOSIDES AGAINST THYMIDINE MONOPHOSPHATE KINASE OF M. TUBERCULOSIS
Familiar, Olga
Munier-Lehmann, Helene
Ainsa, Jose-Antonio
Camarasa, Maria-Jose
Perez-Perez, Maria-Jesus
DRUGS OF THE FUTURE, 2009, 34 : 138 - 138

← 1 2 3 4 5 →